• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat.Com: Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8+ T cells

tetano

Editor, Senior Moderator
[h=1]Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8[SUP]+[/SUP] T cells[/h]
[h=1]Abstract[/h] The avian origin A/H7N9 influenza virus causes high admission rates (>99%) and mortality (>30%), with ultimately favourable outcomes ranging from rapid recovery to prolonged hospitalization. Using a multicolour assay for monitoring adaptive and innate immunity, here we dissect the kinetic emergence of different effector mechanisms across the spectrum of H7N9 disease and recovery. We find that a diversity of response mechanisms contribute to resolution and survival. Patients discharged within 2?3 weeks have early prominent H7N9-specific CD8[SUP]+[/SUP] T-cell responses, while individuals with prolonged hospital stays have late recruitment of CD8[SUP]+[/SUP]/CD4[SUP]+[/SUP] T cells and antibodies simultaneously (recovery by week 4), augmented even later by prominent NK cell responses (recovery >30 days). In contrast, those who succumbed have minimal influenza-specific immunity and little evidence of T-cell activation. Our study illustrates the importance of robust CD8[SUP]+[/SUP] T-cell memory for protection against severe influenza disease caused by newly emerging influenza A viruses.


full article

http://www.nature.com/ncomms/2015/150513/ncomms7833/full/ncomms7833.html#close
 
Back
Top Bottom